Pancreatic Cancer Research

ResearcherUniversität UlmNo recent work listed

Johannes Lemke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-2142-6097; OpenAlex author ID A5021243373. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: 3 papers · 2019: none · 2020: none · 2021: 2 papers

Papers 9

  1. The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death. Co-author DOI 10.21873/anticanres.15416↗
  2. A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Co-author DOI 10.3390/cancers13112539↗
  3. The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells. Co-author DOI 10.1038/s41419-018-0478-0↗
  4. Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy. Last author DOI 10.3390/cancers10030077↗
  5. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/ijms19103219↗
  6. CDK9 is a prognostic marker and therapeutic target in pancreatic cancer. Last author DOI 10.1177/1010428317694304↗
  7. Endogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer In Vitro and In Vivo. Co-author DOI 10.3390/ijms18040716↗
  8. Brain metastasis in pancreatic cancer. Co-author DOI 10.3390/ijms14024163↗
  9. Long-term survival following resection of brain metastases from pancreatic cancer. Co-author PMID 22199336↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marko Kornmann · 5 shared papers, 2011–2021 · strength 0.41
  2. Anna-Laura Kretz · 4 shared papers, 2017–2021 · strength 0.40
  3. Jan-Philipp Ruff · 2 shared papers, 2018–2021 · strength 0.24
  4. Benno Traub · 2 shared papers, 2017–2021 · strength 0.23
  5. Silvia von Karstedt · 2 shared papers, 2018 · strength 0.18
  6. Anna Trauzold · 2 shared papers, 2018 · strength 0.16
  7. Alica K. Beutel · 1 shared paper, 2021 · strength 0.11
  8. Hans Armin Kestler · 1 shared paper, 2021 · strength 0.11
  9. Élodie Roger · 1 shared paper, 2021 · strength 0.11
  10. Thomas Jens Ettrich · 1 shared paper, 2021 · strength 0.11
  11. Johann Gout · 1 shared paper, 2021 · strength 0.11
  12. Alexander Kleger · 1 shared paper, 2021 · strength 0.11
  13. Martin Müller · 1 shared paper, 2021 · strength 0.11
  14. Thomas Theodor Werner Seufferlein · 1 shared paper, 2021 · strength 0.11
  15. Lukas Perkhofer · 1 shared paper, 2021 · strength 0.11
  16. Balbina García-Reyes · 1 shared paper, 2018 · strength 0.09
  17. Yongsu Ma · 1 shared paper, 2017 · strength 0.07
  18. Karen Legler · 1 shared paper, 2018 · strength 0.07
  19. Christoph Röcken · 1 shared paper, 2018 · strength 0.07
  20. Holger Kalthoff · 1 shared paper, 2018 · strength 0.07
  21. Markus Sebastian Juchems · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.